← Back to Analyst Consensus 
OKUR Buy
OnKure Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 12
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 5, 2026 (10 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 14, 2026 | Oppenheimer | reiterate | Outperform → Outperform | — | 52% |
| Jul 20, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Mar 16, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| Aug 26, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $34 | 44% |
| Mar 18, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $34 | 44% |
| Mar 11, 2025 | Oppenheimer | maintain | Outperform → Outperform | $30 | 52% |
| Jan 28, 2025 | Jones Trading | initiate | — → Buy | $32 | 50% |
| Dec 5, 2024 | Leerink Partners | initiate | — → Outperform | $33 | 50% |
| Nov 8, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $40 | 44% |
| Oct 10, 2024 | Oppenheimer | initiate | — → Outperform | $35 | 52% |
Price Target Trend
May 12, 2026 Oct 26, 2026
EPS Estimates
0y —
+1y —
+1q —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days